In the subgroup analysis of traditional cardiovascular risk factors, moreover, there was no evidence of heterogeneity in the association of serum LBP concentration with the risk of MetS between subgroups of each risk factor (all P for heterogeneity ≥0.18) (eTable 3). Here, LBP is linked to metabolic syndrome.